Related Experiment Video
Updated: Aug 28, 2025

In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
Regulation of Tumor and Metastasis Initiation by Chemokine Receptors
Anthony DiNatale1,2, Maria Sofia Castelli1,3, Bradley Nash1
1Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Abstract:
Tumor-initiating cells (TICs) are a rare sub-population of cells within the bulk of a tumor that are major contributors to tumor initiation, metastasis, and chemoresistance. TICs have a stem-cell-like phenotype that is dictated by the expression of master regulator transcription factors, including OCT4, NANOG, and SOX2. These transcription factors are expressed via activation of multiple signaling pathways that drive cancer initiation and progression. Importantly, these same signaling pathways can be activated by select chemokine receptors. Chemokine receptors are increasingly being revealed as major drivers of the TIC phenotype, as their signaling can lead to activation of stemness-controlling transcription factors. Additionally, the cell surface expression of chemokine receptors provides a unique therapeutic target to disrupt signaling pathways that control the expression of master regulator transcription factors and the TIC phenotype. This review summarizes the master regulator transcription factors known to dictate the TIC phenotype, along with the complex signaling pathways that can mediate their expression and the chemokine receptors that are most upstream of this phenotype.
Insights
Tumor-initiating cells (TICs) drive cancer growth and spread. Targeting specific chemokine receptors may disrupt the signaling pathways that maintain TICs, offering a novel therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Tumor-initiating cells (TICs) are crucial for tumor initiation, metastasis, and chemoresistance.
- TICs possess stem-cell-like properties regulated by master transcription factors like OCT4, NANOG, and SOX2.
- These factors are controlled by signaling pathways activated during cancer progression.
Purpose of the Study:
- To review the transcription factors dictating the TIC phenotype.
- To summarize signaling pathways involved in TIC master regulator expression.
- To identify chemokine receptors upstream of TIC phenotype development.
Main Methods:
- Literature review of studies on TICs, transcription factors, signaling pathways, and chemokine receptors.
- Analysis of the interplay between chemokine receptor signaling and stemness pathways.
- Focus on cell surface chemokine receptors as therapeutic targets.
Main Results:
- Master regulator transcription factors (OCT4, NANOG, SOX2) define the TIC phenotype.
- Multiple signaling pathways regulate the expression of these transcription factors.
- Chemokine receptors activate these pathways, driving the TIC phenotype and offering a therapeutic target.
Conclusions:
- Chemokine receptors are key drivers of the TIC phenotype by activating stemness pathways.
- Targeting cell surface chemokine receptors can disrupt TIC signaling.
- This presents a promising strategy for developing new cancer therapies.
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Non-Canonical Wnt Signaling Pathways

